Abstract
Migraine commonly affects adolescents, and menstrual migraine often begins in young girls. If undiagnosed or ineffectively treated, migraine can lead to disability, school absenteeism, emotional or social difficulties, and chronification of headache. Thus, recognizing and accurately diagnosing migraine and menstrual migraine, developing effective treatment strategies (both pharmacologic and nonpharmacologic), and educating both the adolescent and her parents are important in order to minimize the potential early disability of this disorder and limit the otherwise likely progression of migraine to a disabling disorder of adulthood.
Similar content being viewed by others
References and Recommended Reading
Breslau N, Davis GC, Andreski P: Migraine, psychiatric disorders, and suicide attempts: an epidemiologic study of young adults. Psychiatry Res 1991, 37:11–23.
Stewart WF, Linet MS, Celentano DD, et al.: Age and sex-specific incidence rates of migraine with and without visual aura. Am J Epidemiol 1991, 134:1111–1120.
Stovner L, Hagen K, Jensen R, et al.: The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia 2007, 27:193–210.
Brna P, Gordon K, Dooley J: Canadian adolescents with migraine: impaired health-related quality of life. J Child Neurol 2008, 23:39–43.
Sundblad GM, Saartok T, Engstrom LM: Prevalence and co-occurrence of self-rated pain and perceived health in school-children: age and gender differences. Eur J Pain 2006, 11:171–180.
Epstein MT, Hockaday JM, Hockaday TDR: Migraine and reproductive hormones throughout the menstrual cycle. Lancet 1975, 1:543–548.
Martin VT: Simplifying the diagnosis of migraine headache. Adv Stud Med 2004, 4:200–207.
Hershey AD, Winner P, Kabbouche MA, et al.: Use of the ICHD-II criteria in the diagnosis of pediatric migraine. Headache 2005, 45:1288–1297.
Gunner MS, Smith HD, Cromwell PF, Yetman RJ: Practice guideline for diagnosis and management of migraine headaches in children and adolescents: part one. J Pediatr Health Care 2007, 21:327–332.
Romans S, Belaise C, Martin J: Childhood abuse and later medical disorders in women: an epidemiological study. Psychother Psychosom 2002, 71:141–150.
Yucel B, Ozyalcin S, Sertel HO: Childhood traumatic events and dissociative experiences in patients with chronic headache and low back pain. Clin J Pain 2002, 18:394–401.
Graham-Bermann SA, Seng J: Violence exposure and traumatic stress symptoms as additional predictors of health problems in high-risk children. J Pediatr 2005, 146:349–354.
Dyb G, Holmen TL, Zwart J: Analgesic overuse among adolescents with headache: the Head-HUNT-Youth Study. Neurology 2006, 66:198–201.
Cuvellier JC, Couttenier F, Joriot-Chekaf S, Vallee L: Chronic daily headache in French children and adolescents. Pediatr Neurol 2008, 38:93–98.
Pakalnis A, Butz C, Splaingard D, et al.: Emotional problems and prevalence of medication overuse in pediatric chronic daily headache. J Child Neurol 2007, 22:1356–1359.
Edelson RN: Menstrual migraine and other hormonal aspects of migraine. Headache 1985, 25:376–379.
Scher AI, Stewart WS, Lipton RB: Caffeine as a risk factor for chronic daily headache: a population-based study. Neurology 2004, 63:2022–2027.
Lewis DL, Yonker M, Winner P, Sowell M: The treatment of pediatric migraine. Pediatr Ann 2005, 34:449–460.
Gunner KB, Smith HD, Ferguson LE: Practice guideline for diagnosis and management of migraine headaches in children and adolescents: part two. J Pediatr Health Care 2008, 22:52–59.
Unger J: Pediatric migraine: clinical pearls in diagnosis and therapy. Consult Pediatr 2006, 5:545–551.
Pinhas-Hamiel O, Frumin K, Gabis L, et al.: Headaches in overweight children and adolescents referred to a tertiary-care center in Israel. Obesity 2008, 16:659–663.
Szekely B, Merryman S, Croft H, et al.: Prophylactic effects of naproxen sodium on perimenstrual headache: a double blind placebo controlled study. Cephalalgia 1989, 9(Suppl 10):452–453.
Linder SL, Mathew NT, Cady RK, et al.: Efficacy and tolerability of almotriptan in adolescents: a randomized, double-blind, placebo-controlled trial. Headache 2008 May 14 (Epub ahead of print).
Lewis DW, Winner P, Hershey AD, et al.: Efficacy of zolmitriptan nasal spray in adolescent migraine. Pediatrics 2007, 120:390–396.
Evers S, Rahmann A, Kraemer C, et al.: Treatment of childhood migraine attacks with oral zolmitriptan and ibuprofen. Neurology 2006, 67:497–499.
Loder EW, Buse DC, Golub JR: Headache as a side effect of combination estrogen-progestin oral contraceptives: a systematic review. Am J Obstet Gynecol 2005, 193:636–649.
Dalton K: Migraine and oral contraceptives. Headache 1976, 15:247–251.
Sances G, Martignoni E, Fioroni L, et al.: Naproxen sodium in menstrual migraine prophylaxis: a double-blind placebo controlled study. Headache 1990, 30:705–709.
Al-Waili NS: Treatment of menstrual migraine with prostaglandin synthesis inhibitor mefenamic acid: double-blind study with placebo. Eur J Med Res 2000, 5:176–182.
Newman LC, Lipton RB, Lay CL, Solomon S: A pilot study of oral sumatriptan as intermittent prophylaxis of menstruation-related migraine. Neurology 1998, 51:307–309.
Newman L, Mannix LK, Landy S, et al.: Naratriptan as short-term prophylaxis of menstrually associated migraine: a randomized, double-blind, placebo-controlled study. Headache 2001, 41:248–256.
Silberstein SD, Elkin AH, Schreiber C, Keywood C: A randomized trial of frovatriptan for the intermittent prevention of menstrual migraine. Neurology 2004, 63:261–269.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lay, C.L., Broner, S.W. Adolescent issues in migraine: A focus on menstrual migraine. Current Science Inc 12, 384–387 (2008). https://doi.org/10.1007/s11916-008-0065-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11916-008-0065-7